1. "2008"
  2. "Body Imaging Service"
Formats
  1. Journal Article (36)
  2. Meeting Abstract (18)
  3. Book Section (4)
  4. Conference Paper (1)
Groups
  1. Body Imaging Service (59)
  2. Radiology, Department of (59)
  3. Department of Medicine (29)
  4. Solid Tumor Oncology Division (25)
  5. Biostatistics Service (16)
  6. Epidemiology and Biostatistics (16)

More Groups

People
  1. Lawrence Schwartz (25)
  2. Clifford Hudis (6)
  3. Yuman Fong (6)
  4. Hedvig Hricak (5)
  5. Jurgen Rademaker (5)
  6. Michael D'Angelica (5)

More People

Years
  1. 2008 (59)
Publications
  1. Journal of Clinical Oncology (13)
  2. Radiologic Clinics of North America (5)
  3. Annals of Oncology (4)
  4. Radiology (4)
  5. American Journal of Roentgenology (3)
  6. Annals of Surgery (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (13)
  2. Elsevier Inc. (7)
  3. Lippincott Williams & Wilkins (5)
  4. Oxford University Press (4)
  5. Radiological Society of North America, Inc. (4)
  6. American Roentgen Ray Society (3)

More Publishers

Results (59)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of docetaxel (D) followed by flavopiridol (F) in advanced, gemcitabine-refractory pancreatic cancer (PC)
    Meeting Abstract

    Carvajal, R. D.; Shah, M. A.; Tse, A.; Lefkowitz, R.; Kelsen, D. P.; Schwartz, G. K.; O'Reilly, E. M.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Assessing changes in tumor size with CT scans in lung cancer: Are volumetric measurements better than unidimensional (1D) and bidimensional (2D) assessments?
    Meeting Abstract

    Pietanza, M.; James, L. P.; Schwartz, L. H.; Ginsberg, M. S.; Zhao, B.; Moskowitz, C. S.; Zheng, J.; Rizvi, N. A.; Kris, M. G.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Reproducibility of computed tomography (CT) measurements of lung cancer
    Meeting Abstract

    James, L. P.; Zhao, B.; Moskowitz, C. S.; Riely, G. J.; Miller, V. A.; Guo, P.; Ginsberg, M. S.; Kris, M. G.; Schwartz, L. H.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase I trial of bevacizumab plus sunitinib in patients with metastatic renal cell carcinoma
    Meeting Abstract

    Feldman, D. R.; Ginsberg, M. S.; Baum, M.; Flombaum, C.; Hassoun, H.; Velasco, S.; Fischer, P.; Ishill, N. M.; Ronnen, E. A.; Motzer, R. J.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Hepatic arterial infusional (HAI) therapy in patients with unresectable primary liver cancer: Use of dynamic contrast enhanced MRI to evaluate response
    Meeting Abstract

    Jarnagin, W. R.; Schwartz, L. H.; Gultekin, D. H.; Gonen, M.; Haviland, D.; Blumgart, L. H.; D'Angelica, M. I.; Fong, Y.; DeMatteo, R. P.; Kemeny, N. E.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase II trial of the Hsp90 inhibitor tanespimycin (Tan) + trastuzumab (T) in patients (pts) with HER2-positive metastatic breast cancer (MBC)
    Meeting Abstract

    Modi, S.; Sugarman, S.; Stopeck, A.; Linden, H.; Ma, W.; Kersey, K.; Johnson, R. G.; Rosen, N.; Hannah, A. L.; Hudis, C. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase II study of weekly nanoparticle albumin bound (nab)paclitaxel with carboplatin and trastuzumab as 1st-line therapy for HER2-positive metastatic breast cancer (MBC)
    Meeting Abstract

    Seidman, A. D.; Conlin, A. K.; Bach, A.; Brufsky, A. M.; Saleh, M. N.; Lake, D.; Dickler, M. N.; D'Andrea, G.; Traina, T. A.; Hudis, C. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • A novel capecitabine dosing schedule combined with bevacizumab is safe and active in patients with metastatic breast cancer: A phase II study
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Dugan, U.; Feigin, K.; Patil, S.; Edwards, C.; Norton, L.; Hudis, C. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • A phase II evaluation of lapatinib (L) and bevacizumab (B) in HER2+ metastatic breast cancer (MBC)
    Meeting Abstract

    Rugo, H. S.; Franco, S.; Munster, P.; Stopeck, A.; Ma, W.; Lyandres, J.; Lahiri, S.; Arbushites, M.; Koehler, M.; Dickler, M. N.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Abiraterone acetate and prednisone in patients (Pts) with progressive metastatic castration resistant prostate cancer (CRPC) after failure of docetaxel-based chemotherapy
    Meeting Abstract

    Danila, D. C.; Rathkopf, D. E.; Morris, M. J.; Slovin, S. F.; Schwartz, L. H.; Farmer, K.; Anand, A.; Haqq, C.; Fleisher, M.; Scher, H. I.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save